Maximizing Safety and Efficacy of ADCs in Patients With HER2-Low or Ultralow mBC

Content Format:

Slideset

Credit Type:

--

Credits:

--
HER2+ Metastatic Breast Cancer: Expert Perspectives on Sequencing of Therapy and Navigating Brain Metastases

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.75
Expert Thoughts on Navigating Complexities in HER2+ MBC Sequencing

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Sequencing Nuances: Managing Complexities and Brain Metastases

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Sequencing HER2-Positive MBC: Expert Insights and Emerging Data

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Sequencing HER2+ Metastatic Breast Cancer Care Beyond Second-line Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Thoughts on Sequencing Therapy for Patients With HER2+ Metastatic Breast Cancer 

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Medical Minute: Recent Advances in HER2-, HER3-, and TROP2-Targeted Therapies for Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
From Congress to Clinic: A Post-ESMO Breast Cancer 2021 Update on Immune-Based Therapies in Triple-Negative Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Antibody–Drug Conjugates Targeting Cell Surface Receptors in TNBC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
The Evolution of Antibody–Drug Conjugates in Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
ExpressPoints: The Evolution of Antibody–Drug Conjugates in Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Next-Generation HER2-Directed ADCs in Development

Content Format:

Slideset Download

Credit Type:

--

Credits:

--